Here's the live share price of Sudeep Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Sudeep Pharma | -9.17 | -7.08 | 26.62 | 68.57 | 36.98 | 11.06 | 6.50 |
| Sun Pharmaceutical Industries | -1.93 | -4.69 | -9.86 | 3.08 | 5.73 | 15.51 | 15.77 |
| Divi's Laboratories | -5.74 | -1.74 | 25.67 | 46.19 | 37.67 | 35.15 | 10.94 |
| Torrent Pharmaceuticals | -2.46 | -5.28 | -7.59 | 10.54 | 30.54 | 33.95 | 24.03 |
| Zydus Lifesciences | -2.60 | 2.27 | -0.87 | 20.09 | 14.79 | 23.95 | 15.61 |
| Laurus Labs | -0.92 | 5.88 | 30.53 | 82.28 | 132.27 | 72.23 | 25.62 |
| Cipla | -1.25 | -3.54 | -8.74 | 7.03 | -15.47 | 4.08 | 7.57 |
| Dr. Reddy's Laboratories | 0.97 | 5.60 | -2.54 | -0.34 | -1.87 | 3.41 | 4.12 |
| Aurobindo Pharma | -1.49 | -0.30 | 6.90 | 20.68 | 47.75 | 22.22 | 17.96 |
| Mankind Pharma | -6.60 | 1.81 | -7.92 | 9.78 | -4.35 | 8.68 | 10.35 |
| Lupin | -2.61 | -4.89 | -20.84 | -16.43 | 0.89 | 17.72 | 15.62 |
| Glenmark Pharmaceuticals | -1.85 | -5.49 | -2.65 | -0.69 | 18.52 | 41.19 | 33.73 |
| Alkem Laboratories | -2.72 | 1.14 | -6.87 | -6.50 | -5.11 | 13.05 | 6.02 |
| Biocon | -2.57 | -7.81 | -19.68 | 0.23 | -0.14 | 11.39 | 0.20 |
| Abbott India | 0.23 | 0.01 | -4.99 | 0.68 | -13.14 | 5.19 | 3.95 |
| Gland Pharma | -3.46 | 5.64 | 22.35 | 73.29 | 58.59 | 24.55 | -4.24 |
| Ipca Laboratories | -1.27 | -1.02 | 4.05 | 30.11 | 46.78 | 25.72 | 9.60 |
| Anthem Biosciences | -4.40 | -10.01 | 13.06 | 16.30 | 9.79 | 5.11 | 3.03 |
| GlaxoSmithKline Pharmaceuticals | -3.51 | -9.71 | 3.14 | 5.60 | -8.04 | 18.18 | 11.39 |
| Ajanta Pharma | -6.35 | -4.66 | -2.09 | 15.75 | 39.73 | 23.97 | 17.77 |
Source: Dion Global
Over the last one year, Sudeep Pharma has gained 36.98% compared to peers like Sun Pharmaceutical Industries (5.73%), Divi's Laboratories (37.67%), Torrent Pharmaceuticals (30.54%). From a 5 year perspective, Sudeep Pharma has underperformed peers relative to Sun Pharmaceutical Industries (15.77%) and Divi's Laboratories (10.94%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,101.5 | 1,085.44 |
| 10 | 1,141.62 | 1,120.3 |
| 20 | 1,149.04 | 1,143.35 |
| 50 | 1,133.37 | 1,104.05 |
| 100 | 967.91 | 1,000.01 |
| 200 | 796.3 | 815.49 |
Source: Dion Global
In the latest quarter, Sudeep Pharma remained same as its previous close in promoter holding, while DII stake decreased to 14.06%, FII holding rose to 2.93%, and public shareholding moved up to 6.87% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 20,02,038 | 0.77 | 242.19 | |
| 13,60,000 | 2.84 | 164.52 | |
| 6,87,500 | 6.73 | 83.17 | |
| 6,87,500 | 1.24 | 83.17 | |
| 4,37,521 | 1.63 | 52.93 | |
| 3,24,794 | 3.19 | 39.29 | |
| 3,05,039 | 0.59 | 36.9 | |
| 2,40,000 | 1.62 | 29.03 | |
| 1,88,236 | 1.36 | 22.77 | |
| 1,72,239 | 0.22 | 20.84 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 07, 2026, 10:55 PM IST IST | Sudeep Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 05, 2026, 10:28 PM IST IST | Sudeep Pharma - Announcement under Regulation 30 (LODR)-Change in Management |
| Sep 23, 2026, 08:37 PM IST IST | Sudeep Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 22, 2026, 06:13 AM IST IST | Sudeep Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 16, 2026, 04:44 PM IST IST | Sudeep Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Source: Dion Global
Sudeep Pharma Ltd. is a Public Limited Listed company incorporated on 21/12/1989 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24231GJ1989PLC013141 and registration number is 013141. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 338.51 Cr. and Equity Capital is Rs. 11.29 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sudeep Pharma is ₹1,059.80 as on Oct 14, 2026.
The Sudeep Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Sudeep Pharma is ₹11,970.30 Cr as on Oct 14, 2026.
Today’s highest and lowest price of Sudeep Pharma are ₹1,060.10 and ₹998.60.
The 52-week high/low is the highest and lowest price at which Sudeep Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Sudeep Pharma is ₹1,376.00 and 52-week low of Sudeep Pharma is ₹524.95 as on Oct 14, 2026.
The Sudeep Pharma has shown returns of 4.5% over the past day, -7.08% for the past month, 26.62% over 3 months, 36.98% over 1 year, 11.06% across 3 years, and 6.5% over 5 years.
P/E ratio of and PB ratio of Sudeep Pharma are 65.54 and 12.96 on Oct 14, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global